Showing results (171-180 of 4,126) with videos related to
Sort By:
Pageof 413
Plos One|April 2, 2026
Feasibility and agreement between TTE and intracavitary ECG for PICC tip positioning in adult oncology patients: A single-centre exploratory studyKai Xin, Mian Zhou, Yubiao Kang, et al.Oncotargets and Therapy|February 13, 2016
Biomarkers predicting resistance to epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer with wild-type KRASJiang Liu, Jing Hu, Lei Cheng, et al.Frontiers in Oncology|November 1, 2021
AGIG Chemo-Immunotherapy in Patients With Advanced Pancreatic Cancer: A Single-Arm, Single-Center, Phase 2 StudyWangshu Dai, Xin Qiu, Changchang Lu, et al.BMC Complementary and Alternative Medicine|May 2, 2012
Synergistic anti-proliferative effects of gambogic acid with docetaxel in gastrointestinal cancer cell linesZhengyun Zou, Li Xie, Jia Wei, et al.Oncotargets and Therapy|April 3, 2025
Genomic Insights Into Early Relapsed Breast Cancer: Prognostic Challenges and Mutation LandscapeYixuan Wang, Lianru Zhang, Yanan Du, et al.Cancer Biotherapy & Radiopharmaceuticals|May 21, 2013
Synergistic antiangiogenic activity of tetrandrine combined with Endostar on the human umbilical vein endothelial cell modelXiaoping Qian, Bo Yan, Xuefei Zhou, et al.BMC Cancer|April 12, 2008
ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and/or docetaxelLifeng Wang, Jia Wei, Xiaoping Qian, et al.Oncotarget|April 19, 2017
The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapyShenying Jin, Bo Xu, Lixia Yu, et al.Cancer Cell International|January 19, 2025
Construction of feature selection and efficacy prediction model for transformation therapy of locally advanced pancreatic cancer based on CT, 18F-FDG PET/CT, DNA mutation, and CA199Liang Qi, Xiang Li, Jiayao Ni, et al.Pageof 413